Turtlemint Fintech IPO Day 2: Issue subscribed 47%; Check GMP and other key details

Turtlemint Fintech Solutions' IPO entered its second day of bidding on Monday with steady investor participation, garnering an overall subscription of 47% against the 3.29 crore shares on offer.

While retail investors have subscribed to 39% of their reserved quota so far, institutional interest has been stronger, with the Qualified Institutional Buyers (QIBs) segment already witnessing 73% subscription, reflecting robust demand from large investors.

The IPO of the insurance distribution platform will remain open for subscription until June 23.


The public issue consists of a fresh issue of Rs 660.7 crore and an offer for sale (OFS) worth Rs 221.9 crore, taking the total issue size to approximately Rs 883 crore. The company has set the IPO price band at Rs 144-152 per share.

Turtlemint Fintech IPO subscription status: Day 2

As of 10:20 AM on Day 2, the issue was subscribed 0.47 times, according to BSE data.

Retail Individual Investors (RIIs): 39% subscribed against 60.46 lakh shares reserved.

Non-Institutional Investors (NIIs): 2% subscribed against 90.72 lakh shares allocated.

Qualified Institutional Buyers (QIBs): 73% subscribed against 1.77 crore shares earmarked for institutions.

With retail participation picking up and institutional investors showing early interest, market watchers will closely track subscription trends in the final days of the issue.

Turtlemint Fintech Solutions' IPO GMP indicates cautious listing expectations

In the grey market, Turtlemint Fintech shares were trading at a premium of around 1% over the upper price band, suggesting a largely flat-to-muted listing outlook. Based on current GMP trends, the stock is expected to debut near Rs 153 per share.

About the company

Turtlemint is a tech-driven insurance distribution platform that brings together customers, insurance advisors, and insurers through its digital ecosystem. The company operates one of India’s largest Point of Sales Person (PoSP) networks, comprising over 5.07 lakh certified PoSPs and 6.32 lakh digital partners, offering a wide range of life, health, and motor insurance products. Beyond insurance, Turtlemint has also diversified into mutual fund and loan distribution.

The company intends to deploy the fresh issue proceeds towards strengthening its technology and product capabilities, expanding cloud infrastructure, boosting marketing efforts, meeting lease obligations, funding the working capital needs of its subsidiary, and pursuing strategic inorganic growth opportunities.

On the financial front, Turtlemint posted a strong recovery in FY25, reporting revenue of Rs 662.7 crore. However, the company remained in the red, recording a net loss of Rs 194 crore during the fiscal year.

Brokerages remain mixed

SMIFS has assigned a 'Subscribe' rating to the IPO, citing Turtlemint's leadership in the PoSP distribution business, nationwide reach, diversified insurer partnerships and long-term growth opportunities in India's underpenetrated insurance market.

According to SMIFS, the company is well positioned to capitalise on increasing insurance adoption, enhanced advisor productivity, AI-driven automation, cross-selling opportunities, and expansion into adjacent financial services segments.

In contrast, Swastika Investmart has recommended investors 'Avoid' the issue, arguing that the IPO is better suited for long-term investors with a higher risk appetite who are willing to bet on the company's market leadership. The brokerage believes the offering may not appeal to investors seeking quick listing gains.

Meanwhile, with the grey market premium (GMP) hovering at a modest 1%, market sentiment points to a subdued listing. While near-term gains appear limited, the long-term investment thesis will hinge on Turtlemint's ability to leverage its scale and convert growth into sustainable profitability.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)